Literature DB >> 24794440

Immune cell Toll-like receptor 4 mediates the development of obesity- and endotoxemia-associated adipose tissue fibrosis.

Isabelle K Vila1, Pierre-Marie Badin1, Marie-Adeline Marques1, Laurent Monbrun1, Corinne Lefort1, Lucile Mir1, Katie Louche1, Virginie Bourlier1, Balbine Roussel1, Philippe Gui2, Jacques Grober3, Vladimír Štich4, Lenka Rossmeislová4, Alexia Zakaroff-Girard5, Anne Bouloumié5, Nathalie Viguerie1, Cedric Moro1, Geneviève Tavernier1, Dominique Langin6.   

Abstract

Adipose tissue fibrosis development blocks adipocyte hypertrophy and favors ectopic lipid accumulation. Here, we show that adipose tissue fibrosis is associated with obesity and insulin resistance in humans and mice. Kinetic studies in C3H mice fed a high-fat diet show activation of macrophages and progression of fibrosis along with adipocyte metabolic dysfunction and death. Adipose tissue fibrosis is attenuated by macrophage depletion. Impairment of Toll-like receptor 4 signaling protects mice from obesity-induced fibrosis. The presence of a functional Toll-like receptor 4 on adipose tissue hematopoietic cells is necessary for the initiation of adipose tissue fibrosis. Continuous low-dose infusion of the Toll-like receptor 4 ligand, lipopolysaccharide, promotes adipose tissue fibrosis. Ex vivo, lipopolysaccharide-mediated induction of fibrosis is prevented by antibodies against the profibrotic factor TGFβ1. Together, these results indicate that obesity and endotoxemia favor the development of adipose tissue fibrosis, a condition associated with insulin resistance, through immune cell Toll-like receptor 4.
Copyright © 2014 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24794440     DOI: 10.1016/j.celrep.2014.03.062

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  64 in total

1.  Telmisartan Therapy Does Not Improve Lymph Node or Adipose Tissue Fibrosis More Than Continued Antiretroviral Therapy Alone.

Authors:  Netanya S Utay; Douglas W Kitch; Eunice Yeh; Carl J Fichtenbaum; Michael M Lederman; Jacob D Estes; Claire Deleage; Clara Magyar; Scott D Nelson; Karen L Klingman; Barbara Bastow; Amneris E Luque; Grace A McComsey; Daniel C Douek; Judith S Currier; Jordan E Lake
Journal:  J Infect Dis       Date:  2018-05-05       Impact factor: 5.226

2.  Adipose tissue fibrosis, hypertrophy, and hyperplasia: Correlations with diabetes in human obesity.

Authors:  Lindsey A Muir; Christopher K Neeley; Kevin A Meyer; Nicki A Baker; Alice M Brosius; Alexandra R Washabaugh; Oliver A Varban; Jonathan F Finks; Brian F Zamarron; Carmen G Flesher; Joshua S Chang; Jennifer B DelProposto; Lynn Geletka; Gabriel Martinez-Santibanez; Niko Kaciroti; Carey N Lumeng; Robert W O'Rourke
Journal:  Obesity (Silver Spring)       Date:  2016-03       Impact factor: 5.002

3.  Irf5 deficiency in macrophages promotes beneficial adipose tissue expansion and insulin sensitivity during obesity.

Authors:  Elise Dalmas; Amine Toubal; Fawaz Alzaid; Katrina Blazek; Hayley L Eames; Kristell Lebozec; Maria Pini; Isabelle Hainault; Emilie Montastier; Raphaël G P Denis; Patricia Ancel; Amélie Lacombe; Yin Ling; Omran Allatif; Céline Cruciani-Guglielmacci; Sébastien André; Nathalie Viguerie; Christine Poitou; Vladimir Stich; Alexandra Torcivia; Fabienne Foufelle; Serge Luquet; Judith Aron-Wisnewsky; Dominique Langin; Karine Clément; Irina A Udalova; Nicolas Venteclef
Journal:  Nat Med       Date:  2015-05-04       Impact factor: 53.440

Review 4.  The ominous triad of adipose tissue dysfunction: inflammation, fibrosis, and impaired angiogenesis.

Authors:  Clair Crewe; Yu Aaron An; Philipp E Scherer
Journal:  J Clin Invest       Date:  2017-01-03       Impact factor: 14.808

Review 5.  Does bariatric surgery improve adipose tissue function?

Authors:  H Frikke-Schmidt; R W O'Rourke; C N Lumeng; D A Sandoval; R J Seeley
Journal:  Obes Rev       Date:  2016-06-08       Impact factor: 9.213

6.  Subcutaneous Fat Fibrosis Links Obesity to Insulin Resistance in Chinese Americans.

Authors:  Diana L Alba; Jeffrey A Farooq; Matthew Y C Lin; Anne L Schafer; John Shepherd; Suneil K Koliwad
Journal:  J Clin Endocrinol Metab       Date:  2018-09-01       Impact factor: 5.958

7.  A PRDM16-Driven Metabolic Signal from Adipocytes Regulates Precursor Cell Fate.

Authors:  Wenshan Wang; Jeff Ishibashi; Sophie Trefely; Mengle Shao; Alexis J Cowan; Alexander Sakers; Hee-Woong Lim; Sean O'Connor; Mary T Doan; Paul Cohen; Joseph A Baur; M Todd King; Richard L Veech; Kyoung-Jae Won; Joshua D Rabinowitz; Nathaniel W Snyder; Rana K Gupta; Patrick Seale
Journal:  Cell Metab       Date:  2019-05-30       Impact factor: 27.287

8.  A muscle-specific UBE2O/AMPKα2 axis promotes insulin resistance and metabolic syndrome in obesity.

Authors:  Isabelle K Vila; Mi Kyung Park; Stephanie Rebecca Setijono; Yixin Yao; Hyejin Kim; Pierre-Marie Badin; Sekyu Choi; Vihang Narkar; Sung-Woo Choi; Jongkyeong Chung; Cedric Moro; Su Jung Song; Min Sup Song
Journal:  JCI Insight       Date:  2019-07-11

9.  Increased fibrosis: A novel means by which GH influences white adipose tissue function.

Authors:  Lara A Householder; Ross Comisford; Silvana Duran-Ortiz; Kevin Lee; Katie Troike; Cody Wilson; Adam Jara; Mitchell Harberson; Edward O List; John J Kopchick; Darlene E Berryman
Journal:  Growth Horm IGF Res       Date:  2017-12-20       Impact factor: 2.372

Review 10.  Immunological contributions to adipose tissue homeostasis.

Authors:  Joanna R DiSpirito; Diane Mathis
Journal:  Semin Immunol       Date:  2015-11-24       Impact factor: 11.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.